Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For Quarter And Half Year Ended September 30, 2023
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 ,inter alia, to consider and approve Approval of Unaudited Standalone and Consolidated Financial Results for quarter and half year ended September 30, 2023 Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Newspaper Publication Orchid Pharma Ltd - 524372 - Announcement Under Regulation 30 Of SEBI (LODR) Regulation, 2015 - Intimation Of Postal Ballot Process
Announcement under regulation 30 of SEBI (LODR) Regulation, 2015 - Intimation of Postal Ballot Process Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Change in Directorate
Announcement under regulation 30 of SEBI (LODR) Regulation, 2015 - Change in Directorate Orchid Pharma Ltd - 524372 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 Orchid Pharma Ltd - 524372 - Closure of Trading Window
Intimation of Trading window closure Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 30 Of SEBI LODR 2015
Disclosure under Regulation 30 of SEBI LODR 2015 Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulation, 2015 - Road Show Intimation
Disclosure under regulation 30 of SEBI (LODR) Regulation, 2015 - Road Show Intimation Orchid Pharma Ltd - 524372 - Announcement Under Regulation 30 Of SEBI (LODR) Regulation, 2015
Announcement under regulation 30 of SEBI (LODR) Regulation, 2015